CNN quoted Russian officials as saying they were preparing to allow the use of a vaccine prepared by the Gamaleya Institute in Moscow on Aug. 10 or earlier.
Accordingly, the vaccine will be used for the community, first of all the medical staff, Russian officials said.
“It will be a Sputnik moment,” said Kirill Dmitriev, the director of the property fund funding for Russian vaccine research, compared to the Soviet Union’s successful launch of the world’s first satellite in 1957. .
“Americans are surprised when they hear the sound of Sputnik. The same goes for this vaccine. Russia will get there first, ”Dmitriev said.
But Russia has not published any scientific data on the vaccine testing process. Skeptics believe that the vaccine is being hastened by political pressure to bring Russia to the top of the world in science.
There are also concerns that the process of testing vaccines in humans has not been fully implemented. Several dozen COVID-19 vaccine trials are being conducted around the world, but developers note that much work remains to be done before the vaccine is approved for public use.
While some of the world’s vaccines have entered the third phase of testing, Russian vaccines have not yet completed phase 2. Russian units are expected to complete the process on August 3. , then proceed to phase 3 in parallel with the vaccination process for health workers.
Russian scientists say their vaccines are fast because they are based on a vaccine that was created to fight other diseases. Many other companies and countries use this approach.
Moderna, a US-backed vaccine maker and has just started its third beta phase earlier this week, said its vaccine is based on the vaccine used to prevent MERS. Although this approach helps expedite the modulation and testing processes, US and European regulators require full safety and effectiveness testing.
The Russian Defense Ministry said its soldiers volunteered to participate in human trials.
Alexander Ginsburg, the project director, told CNN that he himself had voluntarily vaccinated.
Russian officials say the vaccine approval process has been speeded up because of the global pandemic situation and Russia itself is suffering much. The country has more than 800,000 confirmed cases.
“Our scientists not only focus on taking the lead but also pay attention to the protection of the people,” Mr. Dmitriev said.
The vaccine uses adenovirus vectors in humans who have been weakened so they cannot replicate in the body. Unlike most 2-vector vaccines, patients will receive a second shot to increase the effectiveness of prevention.
Russian officials say that scientific data is being arranged and will be published for review and publication by the researchers in early August.
The World Health Organization says no MERS vaccines are currently approved.
The Russian Ministry of Health has not yet confirmed the approval date for the vaccine in August, but said frontline health workers will be vaccinated before the product is widely used in the community.
Large-scale vaccine trials in the UK, US and several other countries are speeding up, but no deadline has been set for product approval.
Vaccine testing by Oxford University and pharmaceutical firm AstraZeneca showed promising initial results. But Mike Ryan, executive director of the WHO Emergency Program, earlier this month said that “there is still a long way to go”.